FLT4 and neoplasm: Independent of the pro- or anti-tumor nature of tumor lymphatic vessels, it is getting clear that the dysregulation of VEGFR3 is critical in tumor lymphatics, and targeting VEGFR3 to regulate tumor lymphatic vessels could be an ideal way going forward.